Casdin Capital »

UnitedHealth shares owned by Casdin Capital

Quarter-by-quarter ownership of UnitedHealth (UNH) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in UnitedHealth

Tip: Access up to 7 years of quarterly data

All positions including UnitedHealth held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in UnitedHealth by Casdin Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.6M 25k 345.30

More positions owned by Casdin Capital

Genedx Holdings Corp Com Cl A (WGS)
Biolife Solutions Com New (BLFS)
Revolution Medicines (RVMD)
D Fluidigm Corp Del (LAB)
Avidity Biosciences Ord (RNA)
Relay Therapeutics (RLAY)
Illumina (ILMN)
Structure Therapeutics Sponsored Ads (GPCR)
Beam Therapeutics (BEAM)
Alnylam Pharmaceuticals (ALNY)
Tempus Ai Cl A (TEM)
Neurogene (NGNE)
Maze Therapeatics (MAZE)
Prime Medicine (PRME)
Silverback Therapeutics (SPRY)

View all positions for Casdin Capital

Top funds holding UnitedHealth

Vanguard Group
BlackRock
State Street Corporation
Susquehanna International
Geode Capital Management
Capital World Investors
Citadel Advisors
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
Wellington Management Company
Morgan Stanley
Jane Street
FMR
Capital Research Global Investors
Dodge & Cox

View all funds holding UnitedHealth